Amyopathiás dermatomyositis.

Translated title of the contribution: Amyopathic dermatomyositis

K. Dankó, Enikö Simkovics, Orsolya Nagymáté, M. Aleksza, A. Szegedi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Dermatomyositis is a systemic autoimmune disease which belongs to the group of idiopathic inflammatory myopathies. The disease is rare with an incidence of 0.1-1/100,000 and a prevalence of 1-6/100,000. Women are affected twice as often as men. In some patients the disease presents with dermatologic changes weeks to months before the myopathy arises. It was observed that in some patients the myositis develops much later and sometimes not at all. Therefore, the term of dermatomyositis sine myositis used in earlier literature has been changed to amyopathic dermatomyositis. The most important question is whether the patient needs systemic therapy with its possible side effects yet possibly preventing the appearance of myositis or only local therapy for the skin manifestations is necessary. The goal of this article is to summarize the latest findings in amyopathic dermatomyositis.

Original languageHungarian
Pages (from-to)341-346
Number of pages6
JournalOrvosi Hetilap
Volume143
Issue number7
Publication statusPublished - Feb 17 2002

Fingerprint

Myositis
Dermatomyositis
Skin Manifestations
Muscular Diseases
Rare Diseases
Autoimmune Diseases
Amyopathic dermatomyositis
Incidence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dankó, K., Simkovics, E., Nagymáté, O., Aleksza, M., & Szegedi, A. (2002). Amyopathiás dermatomyositis. Orvosi Hetilap, 143(7), 341-346.

Amyopathiás dermatomyositis. / Dankó, K.; Simkovics, Enikö; Nagymáté, Orsolya; Aleksza, M.; Szegedi, A.

In: Orvosi Hetilap, Vol. 143, No. 7, 17.02.2002, p. 341-346.

Research output: Contribution to journalArticle

Dankó, K, Simkovics, E, Nagymáté, O, Aleksza, M & Szegedi, A 2002, 'Amyopathiás dermatomyositis.', Orvosi Hetilap, vol. 143, no. 7, pp. 341-346.
Dankó K, Simkovics E, Nagymáté O, Aleksza M, Szegedi A. Amyopathiás dermatomyositis. Orvosi Hetilap. 2002 Feb 17;143(7):341-346.
Dankó, K. ; Simkovics, Enikö ; Nagymáté, Orsolya ; Aleksza, M. ; Szegedi, A. / Amyopathiás dermatomyositis. In: Orvosi Hetilap. 2002 ; Vol. 143, No. 7. pp. 341-346.
@article{e203f8ee66e74385a875bbd07fb165ed,
title = "Amyopathi{\'a}s dermatomyositis.",
abstract = "Dermatomyositis is a systemic autoimmune disease which belongs to the group of idiopathic inflammatory myopathies. The disease is rare with an incidence of 0.1-1/100,000 and a prevalence of 1-6/100,000. Women are affected twice as often as men. In some patients the disease presents with dermatologic changes weeks to months before the myopathy arises. It was observed that in some patients the myositis develops much later and sometimes not at all. Therefore, the term of dermatomyositis sine myositis used in earlier literature has been changed to amyopathic dermatomyositis. The most important question is whether the patient needs systemic therapy with its possible side effects yet possibly preventing the appearance of myositis or only local therapy for the skin manifestations is necessary. The goal of this article is to summarize the latest findings in amyopathic dermatomyositis.",
author = "K. Dank{\'o} and Enik{\"o} Simkovics and Orsolya Nagym{\'a}t{\'e} and M. Aleksza and A. Szegedi",
year = "2002",
month = "2",
day = "17",
language = "Hungarian",
volume = "143",
pages = "341--346",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "7",

}

TY - JOUR

T1 - Amyopathiás dermatomyositis.

AU - Dankó, K.

AU - Simkovics, Enikö

AU - Nagymáté, Orsolya

AU - Aleksza, M.

AU - Szegedi, A.

PY - 2002/2/17

Y1 - 2002/2/17

N2 - Dermatomyositis is a systemic autoimmune disease which belongs to the group of idiopathic inflammatory myopathies. The disease is rare with an incidence of 0.1-1/100,000 and a prevalence of 1-6/100,000. Women are affected twice as often as men. In some patients the disease presents with dermatologic changes weeks to months before the myopathy arises. It was observed that in some patients the myositis develops much later and sometimes not at all. Therefore, the term of dermatomyositis sine myositis used in earlier literature has been changed to amyopathic dermatomyositis. The most important question is whether the patient needs systemic therapy with its possible side effects yet possibly preventing the appearance of myositis or only local therapy for the skin manifestations is necessary. The goal of this article is to summarize the latest findings in amyopathic dermatomyositis.

AB - Dermatomyositis is a systemic autoimmune disease which belongs to the group of idiopathic inflammatory myopathies. The disease is rare with an incidence of 0.1-1/100,000 and a prevalence of 1-6/100,000. Women are affected twice as often as men. In some patients the disease presents with dermatologic changes weeks to months before the myopathy arises. It was observed that in some patients the myositis develops much later and sometimes not at all. Therefore, the term of dermatomyositis sine myositis used in earlier literature has been changed to amyopathic dermatomyositis. The most important question is whether the patient needs systemic therapy with its possible side effects yet possibly preventing the appearance of myositis or only local therapy for the skin manifestations is necessary. The goal of this article is to summarize the latest findings in amyopathic dermatomyositis.

UR - http://www.scopus.com/inward/record.url?scp=0037123083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037123083&partnerID=8YFLogxK

M3 - Article

VL - 143

SP - 341

EP - 346

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 7

ER -